Eukaryotic RNases and their Partners in RNA Degradation and Biogenesis: Part A

Guillaume Chanfreau
Skip to product information

Eukaryotic RNases and their Partners in RNA Degradation and Biogenesis: Part A

Guillaume Chanfreau
Release date:
Kobo eBook
Regular price $136.79
Sale price $136.79 Regular price $171.00
Final Sale. No returns or exchanges.
Oversized: This item will be shipped by appointment through our delivery partner.
Overweight: This item will be shipped by appointment through our delivery partner.

Digital download

Immediate access in your Kobo library

Deliver to

In stock online. Free shipping on orders over $49

Buy online, pick up at Bay & Floor

Free pick up today

Find it in store

Out of stock

Read this title using any of the following Kobo apps and devices:

Desktop
Desktop
eReaders
eReaders
Tablets
Tablets
Android
Android
iOS
iOS
View full details

Overview

ENGLISH

Promotional Details
  • Published date: Dec 31, 2012
  • Language: English
  • Publisher: Academic Press
  • ISBN: 9780124047457
Fuyu Tamanoi is a biochemist who has served on the UCLA School of Medicine and UCLA College faculty since he joined the Department of Microbiology, Immunology & Molecular Genetics in 1993. He became a full professor in 1997. Since 1996, he has been a Director of Signal Transduction Program Area at Jonsson Comprehensive Cancer Center. Dr. Tamanoi earned his B.S. and M.S. in Biochemistry at the University of Tokyo. He received PhD in Molecular Biology at Nagoya University in 1977. He was a postdoctoral fellow at Harvard Medical School, where he worked on bacteriophage DNA replication. From 1980 to 1985, he was a senior staff investigator at Cold Spring Harbor Laboratory, where he worked on adenovirus DNA replication. From 1985 to 1993, he was an Assistant Professor and then Associate Professor at the University of Chicago, where he initiated studies on lipid modification of the Ras family proteins. His laboratory research centers on signal transduction and signal transduction inhibitors. He is currently exploring ways to deliver signal transduction inhibitors using nanoparticles.

Recently Viewed